Target intelligence / Profile preview

SLC45A4 antisense RNA 1 (SLC45A4-AS1)

Target
SLC45A4-AS1
Molecular classification
Other, Long non-coding RNA (lncRNA)
01

Overview

SLC45A4 antisense RNA 1 (SLC45A4-AS1) is a long non-coding RNA (lncRNA) gene located in the human genome, classified as a non-protein-coding RNA[6]. Unlike its sense counterpart SLC45A4, which encodes a polyamine transporter relevant for neuronal function and pain modulation[1][5][7], SLC45A4-AS1 does not encode a functional protein and its specific biological function, implications in disease, or therapeutic potential remains uncharacterized in the available literature and databases[4][6]. The gene is transcribed to RNA, but there is no experimental evidence supporting its role as a biomarker, therapeutic target, or disease mediator. No information is currently available about direct drug interactions, mechanism of action, or clinical biomarkers related to SLC45A4-AS1[4][6]. Information for SLC45A4 (the transporter) should not be confused with SLC45A4-AS1, the antisense lncRNA. There is no evidence SLC45A4-AS1 is an established therapeutic target or has a well-defined role in human disease or pharmacology as of current sources. By convention and current evidence, its classification is best captured as "Other" and "Long non-coding RNA," without specific functional or disease role assignment.

Other names
SLC45A4-AS1
02

Biological functions

Unknown (insufficient data)possible gene regulation (based on typical lncRNA functions)
03

Disease associations

Unknown (no clear association found in current data)

Beyond the preview

Go deeper on SLC45A4 antisense RNA 1 (SLC45A4-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SLC45A4 antisense RNA 1 (SLC45A4-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call